May 11, 2021 | Clinical case

Compare your opinion with peers and Mr. Hugh Mostafid

Which biomarker metric is dependent on disease prevalence, and therefore cannot be compared between different cohorts?

Submit your answer and read the opinion of Mr. Hugh Mostafid.

A) Sensitivity

B) NPV*

* negative predictive value

C) Specificity

Download the free slide resource and brochure

Share this on your favourite network:

All updates

Other updates

May is bladder cancer awareness month

May 10, 2024 | Publication

Improvements in the initial diagnostic workup for bladder cancer Did you know that you can decrease your patient's burden and discomfort during the initial workup for bladder cancer with the implementation of urinary biomarkers? According to the 2024 EAU guidelines...

Exploring the benefits of urinary biomarkers in NMIBC surveillance

Apr 30, 2024 | Interview

Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...

The diagnostic value of urinary biomarkers in UTUC

Feb 2, 2024 | Publication

Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...

Privacy policy

Disclaimers

✉ info@bcamonitor.org